Chu de Limoges - Hospital Dupuytren

Limoges 87042

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Cholangiocarcinoma, Unresectable Cholangiocarcinoma

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early